BSECompany Update1h ago · 22 Jul 2026, 06:42 pm

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Medplus Health Services Ltd · 543427

✦ AI Summary▼ NegativeRegulatory

Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received three suspension orders for drug licenses at stores in Karnataka, resulting in potential revenue loss of Rs 0.49 lacs, Rs 0.12 lacs, and Rs 0.42 lacs for two and one day respectively.

Analysis Scores

Earnings Impact2/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

a7460808-419f-4fca-80bc-6b927c7961dd.pdf

pdf

Download →
View document text
MedPlus Health Services Limited July 22, 2026 The Listing Department The Listing Department BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received three suspension orders for a Drug License of a store situated in the state mentioned below: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Authority Nature and details of the Date of receipt of Details of the Impact on action(s) taken, initiated direction or order, violation(s)/ financial or order(s) passed including any contravention(s) operation or interim or interim committed or alleged other activities of orders, or any to be committed the listed entity, other quantifiable in communication monetary terms from the to the extent authority possible Suspension of Drug Potential Revenue License for two days of Loss of Rs 0.49 store situated at New lacs. Ksrtc Layout Athani Assistant Director, Drugs Road, Karnataka. Control Administration, Vijayapura Circle, Suspension of Drug Potential Revenue Under Rule 65 of Vijayapura, Karnataka. License for one day of Loss of Rs 0.12 Order received on Drugs and Cosmetics store situated at Adarsha lacs. 21.07.2026 Act, 1940 and Drugs Nagar Vijayapura, and Cosmetics Rules, Karnataka. 1945 Assistant Director, Drugs Suspension of Drug Potential Revenue Control Administration License for two days of Loss of Rs 0.42 Chikkaballapura Circle, store situated at lacs. Chikkaballapura, Chinthamani Bangalore Karnataka. Road, Karnataka. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com